Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc. Common Stock

AVLN · Nasdaq

Avalyn Pharma Inc. Common Stock (AVLN) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Avalyn Pharma Inc. Common Stock in 2026. The next earnings report is expected on September 2, 2026.

Scheduled earnings dates

02 Sep 2026 02 Dec 2026

Earnings calendar

Next earnings date

02 Sep 2026

In 13 days

EPS estimate

-0.76

Revenue estimate

0

Past earnings

12 Aug 2026
EPS actual
-0.98 (-26.2%)
estimate -0.78
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
03 Jun 2026
EPS actual
-21.83 (-265.3%)
estimate -5.98
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

Avalyn Pharma missed consensus estimates in its latest earnings report, with EPS of -$0.98 falling short of the -$0.7767 estimate while revenue met expectations at $0. In the prior quarter, EPS missed expectations and revenue similarly met forecasts.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and its corporate headquarters are situated in Boston, Massachusetts.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
Nasdaq
CEO
Lyn Baranowski
Employees
50
IPO date
30 Apr 2026
ISIN
US05348Y1055
Website
avalynpharma.com

Frequently asked questions

When does Avalyn Pharma Inc. Common Stock (AVLN) next report earnings?

Avalyn Pharma Inc. Common Stock (AVLN) is scheduled to report earnings on September 2, 2026.

What was Avalyn Pharma Inc. Common Stock's most recent earnings date?

Avalyn Pharma Inc. Common Stock (AVLN) last reported earnings on August 12, 2026.

Where is Avalyn Pharma Inc. Common Stock stock listed?

Avalyn Pharma Inc. Common Stock (AVLN) is listed on Nasdaq.